Funds and ETFs Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 04:56:40 2024-06-12 am EDT 5-day change 1st Jan Change
324.3 DKK -0.70% Intraday chart for Demant A/S -2.47% +9.46%

ETFs positioned on Demant A/S

Name Weight AuM 1st Jan change Investor Rating
1.55% 15 M€ -3.67%
0.14% 21 M€ +8.21% -
0.12% 5 M€ +10.09% -
0.12% 14 M€ +5.66% -
0.05% 3,859 M€ +18.82% -
0.05% 469 M€ -2.05%
0.05% 6 M€ -.--%
0.03% 6 M€ -.--% -
0.02% 10 M€ -3.35% -
0.02% 200 M€ +11.39% -
0.02% 261 M€ -.--% -
0.02% 488 M€ +14.81%
0.01% 276 M€ +11.40% -
0.01% 284 M€ -.--%
0.01% 607 M€ +0.05% -
0.01% 1,166 M€ +0.26% -
0.01% 206 M€ -.--%
0.01% 288 M€ +22.63%
0.00% 32 M€ +4.30% -
0.00% 414 M€ +10.47% -
0.00% 17 M€ +3.42% -
0.00% 36 M€ +9.87% -
0.00% 7 M€ +0.11% -
0.00% 248 M€ +11.27% -
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
326.6 DKK
Average target price
336.7 DKK
Spread / Average Target
+3.09%
Consensus
  1. Stock Market
  2. Equities
  3. DEMANT Stock
  4. Funds and ETFs Demant A/S